| David Hamilton, MSW, BCD | |
|
12mdos/sgohf, Randolph Afb, TX 78150 | |
| (210) 652-6308 | |
| Not Available |
| Full Name | David Hamilton |
|---|---|
| Gender | Male |
| Speciality | Social Worker - Clinical |
| Location | 12mdos/sgohf, Randolph Afb, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013970672 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | SW-0841I (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| David Hamilton, MSW, BCD 25138 Flying Arrow, San Antonio, TX 78258-2722 Ph: () - | David Hamilton, MSW, BCD 12mdos/sgohf, Randolph Afb, TX 78150 Ph: (210) 652-6308 |
News Archive
Scientists are trying to open a new front in the battle against gum disease, the leading cause of tooth loss in adults and sometimes termed the most serious oral health problem of the 21st century. They described another treatment approach for the condition in a report here today at the 244th National Meeting & Exposition of the American Chemical Society, the world's largest scientific society.
A new article published in the journal PLOS Pathogens on October 10, 2019, claims that the common rotavirus may be responsible for the occurrence of type 1 diabetes, a form of diabetes which occurs in children and is due to destruction of the pancreatic islet cells that produce the hormone insulin to normalize blood glucose levels.
A team of researchers at The University of Kansas Cancer Center have been awarded a five-year, $1.8 million grant from the National Institutes of Health to study chronic inflammation of the liver, a major factor in the development of liver cancer.
Acorda Therapeutics, Inc. today announced that the Company has submitted applications to extend patent protection for AMPYRA™ (dalfampridine) Extended Release Tablets, 10 mg to the United States Patent and Trademark Office.
Could a chemical produced by the brain that regulates mood, sleep and breathing also be protective in people with epilepsy? New research has found that higher levels of serotonin in the blood after a seizure are linked to a lower incidence of seizure-related breathing problems called apneas, when a person temporarily stops breathing.
› Verified 9 days ago
Ms. Rocio Fabiola Rodriguez, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 221 3rd St W, Randolph Afb, TX 78150 Phone: 210-792-1882 |